PLXNA4 and idiopathic pulmonary fibrosis: We found that nintedanib treatment was associated with downregulation of PLXNA4. PLXNA4 is also the predicted target of the upregulated hsa-miR-486-3p in nintedanib-treated IPF fibroblasts.